Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Previous Speakers

Edwin G Moore

Edwin G Moore

University of Illinois USA

Luke S Fisher

Luke S Fisher

Collaborative Drug Discovery, Inc. USA

Panayiotis P Constantinides

Panayiotis P Constantinides

Biopharmaceutical & Drug Delivery Consulting LLC USA

Guiyong (Nick) Song

Guiyong (Nick) Song

The University of Missouri USA

Ebtisam A Aldaais

Ebtisam A Aldaais

Imam Abdulrahman Bin Faisal University Saudi Arabia

Rodney Villanueva

Rodney Villanueva

Atrium Health USA

Naoki Toyooka

Naoki Toyooka

University of Toyama Japan

Prakash V Diwan

Prakash V Diwan

National Institute of Pharmaceutical Education and Research India

CADD and Drug Delivery 2019


CADD and Drug Delivery 2019 is once again pleased to support scientific research in the field of drug development and drug delivery.

The "Canada Meetings on Computer Aided Drug Designing and Drug Delivery" brings together leading drug development and drug delivery scientists from both industry and academia to share and discuss their latest work.

We feel proud to present the highly anticipated Canada Meetings on Computer Aided Drug Designing and Drug Delivery to be held on 27-28 September 2019, Toronto, Canada.

The conference programme consists of world-class keynote addresses, industry-led presentations, as well as extensive networking opportunities, creating an interactive platform for high-level scientific and business discussions. This event covering the latest advances in drug delivery science, while also providing a meeting place to network and form new partnerships.

The program agenda is stuffed with selected talks on topics related to drug development and drug delivery.

Key benefits of attending:

  • Learn about the latest drug delivery technology solutions for both small and large molecule drugs.
  • Network with key decision makers from pharmaceutical, biotechnology, and medical device companies and explore areas for potential collaboration.
  • Discover the current drug delivery needs of pharma and biotech companies and determine what they are looking for in terms of external delivery technologies.
  • Understand the potential impact digital health applications and digitally-enabled drug delivery systems can have on improving patient adherence and overall health outcomes.

Submit us your abstract here @ Abstract Submission.

Key Sessions/Tracks

Track 1: Computer Aided Drug Designing

Track 2 : Advances in Drug Delivery

Track 3 : Drug Delivery Devices

Track  4 : Advancements in Drug Designing

Track 5: Novel Drug Discovery and Drug Delivery

Track 6: Large Molecule Drug Formulation

Track 7: Bioanalysis and Stabilisation

Track 8: ADME

Track 9:  Medicinal Chemistry and Drug Discovery


Track 10: Nanotechnology in Drug Delivery

Track 11:  Chem Virology

Track 12:  Posology

Track 13:  Cancer Studies: Drug Delivery Chemistry

Track 14: Drug Biotransformation and Disposition

Track 15: Small Molecule Drug Formulation

Track 16: Drug Delivery Systems


Global Drug Discovery Market Report

 Global Drug Discovery Market:

The global drug discovery market is expected to register a CAGR of approximately 8.0% during the forecast period, of 2018-2023. Due to the favourable regulatory framework by the governments in the region, North America dominates the market.

Rise in Technology Advancements and Innovations

In the recent past, drug discovery has evolved significantly with emerging technologies, helping the process to become more refined, accurate, and less time consuming. Due to automation, multi-detector readers, imaging hardware and software, high-throughput screening is one of the most widely used drug discovery technologies. There are several other evolving technologies, such as mass spectroscopy, protein and nucleic acid isolation, proteomics, RNAi, nanotechnology, and others, which contribute to advancements and innovations in drug discovery. The pharmaceutical and biotech companies are increasing their collaboration with contract development and manufacturing organizations, thus playing a crucial role in the development and innovation of new drugs.

Other factors contributing to the growth of this market are - rising prevalence of a wide range of diseases (such as cardiovascular and CNS-related disorders), rising healthcare expenditure, and upcoming patent expiration of blockbuster drugs.

Geographical Representation:

The global drug discovery market has been segmented by drug type, technology, service, end user, and geography. By geography, the market has been segmented into North America, Europe, Asia-Pacific, Middle East & Africa, and South America.

Geographically, North America is the most lucrative region in the market, due to the presence of a high number of top pharmaceutical and biotech companies in this region. The favorable regulatory framework and encouraging regulatory policies for investors to research and develop new drugs augment the growth of this market. Other factors, such as high-income population and healthy returns on investments for innovative technologies, are integral to the above factors. Asia-Pacific is expected to register a healthy growth rate, due to rising disposable incomes, economic growth, and increasing investment by the regional pharmaceutical and biotechnology industry.


To Collaborate Scientific Professionals around the World

Conference Date September 27-28, 2019

For Sponsors & Exhibitors

Speaker Opportunity

Supported By

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by